This archive brings together international conference presentations co-authored by Prof. Dr. Selim İsbir. Filter by year to find meeting names, dates, authors and research summaries, with links to original sources where available.
FILTER BY YEAR:
1) Isbir CS, Daly RC, Mullany CJ, Dearani J, Orzsulak TA, McGregor CGA. Use of the internal mammary artery improves results of the combined aortic valve replacement and coronary artery bypass grafting. AHA 71st Scientific Sessions (Dallas, 8–11 Kas 1998). Circulation, 98(17) Suppl I-474, 1997.
Link: link yok
2) Isbir CS, Doğan R, Demircin M, Paşaoğlu İ. The effect of Aprotinin in ischemia-reperfusion injury: Role of membrane bound enzymes. 8th International Symposium on Cardiovascular Pharmacotherapy (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):48, 1999. Link: link yok
3) Isbir CS, Doğan R, Tuncer M, Farsak B, Kılınç K, Aydın M, Paşaoğlu İ. Enalapril maleate in ischemia-reperfusion injury. 8th ISCP (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):49, 1999. Link: link yok
4) Yılmaz H, Ağaçhan B, Aydın M, Isbir CS, Isbir T. Association between apolipoprotein E and ACE genotype in CAD. 3rd Frontiers in Interventional Cardiology (Jerusalem, 27 Haz–1 Tem 1999). Int J Cardiovasc Interv 2(2):49, 1999. Link: link yok
5) Isbir CS, Doğan R, Farsak B, Aydın M, Demircin M. The effect of Captopril on membrane-bound enzymes in I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999). Link: link yok
6) Isbir CS, Doğan R, Farsak B, Aydın M. The effect of Lisinopril on myocardial I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999). Link: link yok
7) Aydın M, Öztürk O, Zeybek Ü, Yaylım İ, Ergen A, Ak K, Isbir CS. The late effect of I/R on oxidant/antioxidant system. Turkish-Italian Joint Meeting on Hypertension & Atherosclerosis (Antalya, 30 Mar–2 Nis 2000). Link: link yok
8) Isbir CS, Akgun S, Yılmaz H, Civelek A, Agachan B, Cobanoglu A. ACE gene polymorphism and failure of AV femoral shunts for hemodialysis. 2nd International Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001). Link: link yok
9) Akgün S, Civelek A, Isbir CS, Çobanoğlu A. Femoral arteriovenous PTFE grafts: Last choice for hemodialysis access. 2nd Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001). Link: link yok
10) Akgün S, Tekeli A, Civelek A, Isbir CS, Ak K, Cobanoglu A. Prevention of lung injury by FK506 following hind limb I/R in rats. 50th E.S.C.V.S. Congress (Budapeşte, 20–23 Haz 2001). Cardiovasc Surg 8:51, 2001. Link: link yok
11) Isbir CS, Ak K, Zeybek U, Akgün S, Diren S, Civelek A, Tekeli A, Sav A, Çobanoğlu A. Ischemic preconditioning and nicotinamide in spinal cord protection. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):114, 2002. Link: link yok
12) Isbir CS, Yildirim T, Akgün S, Civelek A, Arsan S. CABG in severe LV dysfunction. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):84, 2002. Link: link yok
13) Arsan S, Isbir S, Erentug V. Ascending aortic aneurysm repair: replacement or external wrapping. 13th WSCTS (San Diego, 1–5 Kas 2003). J Cardiovasc Surg 5(1):43, 2003. Link: link yok
14) Ak K, Akgün S, Tecimer T, Isbir S, Civelek A, Tekeli A, Atalan N, Arsan S. Histopathological risk factors for postoperative AF in cardiac surgery. 12th ASCVS (İstanbul, 18–22 Nis 2004). Link: link yok
15) Arsan S, Ak K, Akgün S, Civelek A, Isbir S, Aksoy N, Tekeli A, Yıldırım T. Reduction aortoplasty + external wrapping for tubular ascending AA with concomitant ops. 12th ASCVS (İstanbul, 18–22 Nis 2004). Link: link yok
16) Tekeli A, Isbir CS, Civelek A, Akgün S, Ergen A, Kurtkaya O, Sav A, Arsan S. Prevention of lung injury by Iloprost after hind limb I/R in rats. MACCS XVI (26–29 Eyl 2004). Heart Surgery Forum 7 (Suppl 2), 2005. Link: The Heart Surgery Forum (2005 Suppl)
17) Isbir CS, Ak K, Aksoy N, Tekeli A, Civelek A, Tetik S, Birkan Y, Adademir T, Arsan S. Acetylsalicylic acid resistance in CABG. Update in Cardiology & Cardiovascular Surgery (Bodrum, 29 Eyl–2 Eki 2005). Heart Surgery Forum 8(Suppl 1), 2005. Link: The Heart Surgery Forum (2005 Suppl)
18) Isbir CS, Tekeli A, Ak K, Ergen A, Yılmaz H, Adademir T, Civelek A, Atalan N, Arsan S. ACE gene polymorphism and acute renal dysfunction after CABG. 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
19) Tekeli A, Isbir S, Ak K, Atalan N, Adademir T, Civelek A, Arsan S. Does EuroSCORE predict major adverse events? 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
20) Tekeli A, Zeybek Ü, Agachan B, Ergen A, Ak K, Isbir S, Arsan S. IL-6 ve IL-8 polymorphisms after CABG: inflammatory cytokines? 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
21) Adademir T, Tekeli A, Ak K, Birkan Y, Atalan N, Civelek A, Isbir CS, Arsan S. Effect of AKI on early mortality after cardiac surgery. 2nd Update in Cardiology & Cardiovascular Surgery (20–24 Eyl 2006). Heart Surgery Forum 9(1):S9, 2006. Link: link yok
22) Ak K, Adademir T, Gürsu O, Tekeli A, Atalan N, Tetik S, Isbir S, Arsan S. TEG-based transfusion algorithm reduces blood product use after cardiac surgery. 4th Update in Cardiology & Cardiovascular Surgery (28 Kas–2 Ara 2008). Heart Surgery Forum 11(2):S2, 2008. Link: The Heart Surgery Forum (2008 Suppl)
23) Ak K, Adademir T, Isbir S, Gürsu O, Tekeli A, Atalan N, Arsan S. Impact of preoperative anemia on outcome after CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S52, 2008. Link: The Heart Surgery Forum (2008 Suppl)
24) Ak K, Isbir S, Tekeli A, Adademir T, Gürsu O, Güler A, Arsan S. Preoperative IABP support in high-risk CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S60, 2008. Link: The Heart Surgery Forum (2008 Suppl)
25) Ak K, Tetik Ş, Adademir T, Gürsu Ö, Güler A, Isbir S, Yardımcı T, Arsan S. Impact of early statin therapy on tPA and TFPI after CABG. 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S21, 2009. Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde)
26) Arsan S, Ak K, Adademir T, Güler A, Isbir S. Autologous right PA wall for repair of absent PA (TOF+APV). 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S91, 2009. Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde)
27) Ergen A, Kahraman TÖ, Tekeli A, Turan AN, Ekşi YE, Adıgüzel M, Isbir S, Isbir T. Plasma myeloperoxidase in MI. 4th International Congress of Molecular Medicine (İstanbul, 27–30 Haz 2011). Link: link yok
28) Kurnaz Ö, Yılmaz AH, Isbir S, Isbir T. PPAR-γ PRO12ALA ve LOX-1 K167N varyantları ve KAH. 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
29) Görmüş U, Kahraman TÖ, Isbir S, Tekeli A, Isbir T. MMP2 gen polimorfizmi ve mRNA düzeyi (yüzeyel varis). 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
30) Teker Akadam AB, Yılmaz HA, Arat A, Isbir S, Isbir T. Combined effects of ApoE and PCSK9 R496W in CHD. 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
31) Timirci-Kahraman O, Görmüş U, Ergen HA, Tekeli A, Isbir S, Isbir T. mRNA levels of elastin, fibulin-5, LOXL-1, MMP-2/9 in varicose vein. 22nd IUBMB & 37th FEBS (Sevilla, 4–9 Eyl 2012). Link: link yok
32) Birkan Y, Isbir S, Ak K, Elçi E, Dericioğlu O, Arsan S. CD34(+) pluripotent MSC therapy in chronic critical limb ischemia. 14th Asian Society for Vascular Surgery (İstanbul, 26–29 Eki 2013). Link: link yok
33) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S. Five-year results of EVAR for AAA (single center). 14th ASVS (İstanbul, 26–29 Eki 2013). Link: link yok
34) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S. Endovascular graft repair of thoracic aortic pathologies (single center). 14th ASVS (İstanbul, 26–29 Eki 2013). Link: link yok
35) Öztürk NY, Ak K, Erkek N, Isbir S, Arsan S. VV-ECMO in pediatric ICU: early experience. 1st International Critical Care & Emergency Medicine Congress (İstanbul, 6–8 Kas 2013). Link: link yok
36) Yalındağ NO, Ak K, Besci T, Keleş B, Kolbaş N, Erkek N, Isbir S, Arsan S. VV-ECLS for infant with ARDS & airleaks (first success). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):293, 2013. Link: link yok
37) Öztürk NO, Ak K, Yasa U, Barys S, Isbir S, Arsan S, Erkek N, Barlan İ. VV-ECLS weaning without anticoagulation (IPEX, child). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):294, 2013. Link: link yok
38) Isbir S, Baltacioglu F, Ak K, Kararmaz A, Elçi E, Arsan S. Hybrid procedures for extensive aortic pathologies (22 hasta). AATS Aortic Symposium (New York, 24–25 Nis 2014). Link: link yok
39) Birkan Y, Ak K, Dericioğlu O, Isbir S, Arsan S. CD34(+) MSC therapy in chronic critical limb ischemia. 11th International Congress of Update in Cardiology & Cardiovascular Surgery (26–29 Mar 2015). JACC Suppl S6, 2015. Link: link yok
40) Isbir S. Hybrid debranching and endovascular repair of extensive TAAA. EuroPCR (Paris, 19–21 May 2015). Link: EuroPCR 2015 Abstract Book (PDF)
41) Isbir S, Birkan Y. EVH + MECC + Autotransfusion. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
42) Isbir S. Hybrid thoracoabdominal aortic aneurysm repair. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
43) Isbir S. Sutureless valve replacement as a concomitant procedure. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
- Abstract: The impact of internal mammary artery (IMA) use on outcomes of combined aortic valve replacement and CABG (AHA abstract).
2) Isbir CS, Doğan R, Demircin M, Paşaoğlu İ. The effect of Aprotinin in ischemia-reperfusion injury: Role of membrane bound enzymes. 8th International Symposium on Cardiovascular Pharmacotherapy (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):48, 1999. Link: link yok
- Abstract: The effects of aprotinin on membrane enzymes in ischemia–reperfusion injury.
3) Isbir CS, Doğan R, Tuncer M, Farsak B, Kılınç K, Aydın M, Paşaoğlu İ. Enalapril maleate in ischemia-reperfusion injury. 8th ISCP (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):49, 1999. Link: link yok
- Abstract: The effects of enalapril on ischemia–reperfusion injury in an experimental model.
4) Yılmaz H, Ağaçhan B, Aydın M, Isbir CS, Isbir T. Association between apolipoprotein E and ACE genotype in CAD. 3rd Frontiers in Interventional Cardiology (Jerusalem, 27 Haz–1 Tem 1999). Int J Cardiovasc Interv 2(2):49, 1999. Link: link yok
- Abstract: The association of ApoE and ACE genotypes with CAD.
5) Isbir CS, Doğan R, Farsak B, Aydın M, Demircin M. The effect of Captopril on membrane-bound enzymes in I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999). Link: link yok
- Abstract: Captopril and membrane enzymes in ischemia–reperfusion injury.
6) Isbir CS, Doğan R, Farsak B, Aydın M. The effect of Lisinopril on myocardial I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999). Link: link yok
- Abstract: The effects of lisinopril on myocardial ischemia–reperfusion injury.
7) Aydın M, Öztürk O, Zeybek Ü, Yaylım İ, Ergen A, Ak K, Isbir CS. The late effect of I/R on oxidant/antioxidant system. Turkish-Italian Joint Meeting on Hypertension & Atherosclerosis (Antalya, 30 Mar–2 Nis 2000). Link: link yok
- Abstract: Late oxidant and antioxidant effects of ischemia–reperfusion.
8) Isbir CS, Akgun S, Yılmaz H, Civelek A, Agachan B, Cobanoglu A. ACE gene polymorphism and failure of AV femoral shunts for hemodialysis. 2nd International Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001). Link: link yok
- Abstract: The association between ACE polymorphism and arteriovenous shunt failure.
9) Akgün S, Civelek A, Isbir CS, Çobanoğlu A. Femoral arteriovenous PTFE grafts: Last choice for hemodialysis access. 2nd Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001). Link: link yok
- Abstract: Outcomes of femoral arteriovenous PTFE grafts as a vascular access option.
10) Akgün S, Tekeli A, Civelek A, Isbir CS, Ak K, Cobanoglu A. Prevention of lung injury by FK506 following hind limb I/R in rats. 50th E.S.C.V.S. Congress (Budapeşte, 20–23 Haz 2001). Cardiovasc Surg 8:51, 2001. Link: link yok
- Abstract: Prevention of lung injury with FK506 in rats.
11) Isbir CS, Ak K, Zeybek U, Akgün S, Diren S, Civelek A, Tekeli A, Sav A, Çobanoğlu A. Ischemic preconditioning and nicotinamide in spinal cord protection. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):114, 2002. Link: link yok
- Abstract: Experimental spinal cord protection using ischemic preconditioning and nicotinamide.
12) Isbir CS, Yildirim T, Akgün S, Civelek A, Arsan S. CABG in severe LV dysfunction. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):84, 2002. Link: link yok
- Abstract: CABG outcomes in patients with a low ejection fraction.
13) Arsan S, Isbir S, Erentug V. Ascending aortic aneurysm repair: replacement or external wrapping. 13th WSCTS (San Diego, 1–5 Kas 2003). J Cardiovasc Surg 5(1):43, 2003. Link: link yok
- Abstract: Surgical options for ascending aortic aneurysms.
14) Ak K, Akgün S, Tecimer T, Isbir S, Civelek A, Tekeli A, Atalan N, Arsan S. Histopathological risk factors for postoperative AF in cardiac surgery. 12th ASCVS (İstanbul, 18–22 Nis 2004). Link: link yok
- Abstract: Histopathological markers of postoperative atrial fibrillation.
15) Arsan S, Ak K, Akgün S, Civelek A, Isbir S, Aksoy N, Tekeli A, Yıldırım T. Reduction aortoplasty + external wrapping for tubular ascending AA with concomitant ops. 12th ASCVS (İstanbul, 18–22 Nis 2004). Link: link yok
- Abstract: Reduction aortoplasty and external wrapping for a moderately dilated ascending aorta.
16) Tekeli A, Isbir CS, Civelek A, Akgün S, Ergen A, Kurtkaya O, Sav A, Arsan S. Prevention of lung injury by Iloprost after hind limb I/R in rats. MACCS XVI (26–29 Eyl 2004). Heart Surgery Forum 7 (Suppl 2), 2005. Link: The Heart Surgery Forum (2005 Suppl)
- Abstract: Experimental lung protection with iloprost.
17) Isbir CS, Ak K, Aksoy N, Tekeli A, Civelek A, Tetik S, Birkan Y, Adademir T, Arsan S. Acetylsalicylic acid resistance in CABG. Update in Cardiology & Cardiovascular Surgery (Bodrum, 29 Eyl–2 Eki 2005). Heart Surgery Forum 8(Suppl 1), 2005. Link: The Heart Surgery Forum (2005 Suppl)
- Abstract: Aspirin resistance in CABG patients.
18) Isbir CS, Tekeli A, Ak K, Ergen A, Yılmaz H, Adademir T, Civelek A, Atalan N, Arsan S. ACE gene polymorphism and acute renal dysfunction after CABG. 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
- Abstract: The association between ACE polymorphism and AKI after CABG.
19) Tekeli A, Isbir S, Ak K, Atalan N, Adademir T, Civelek A, Arsan S. Does EuroSCORE predict major adverse events? 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
- Abstract: Prediction of major adverse events using EuroSCORE.
20) Tekeli A, Zeybek Ü, Agachan B, Ergen A, Ak K, Isbir S, Arsan S. IL-6 ve IL-8 polymorphisms after CABG: inflammatory cytokines? 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
- Abstract: Cytokine polymorphisms and inflammation after CABG.
21) Adademir T, Tekeli A, Ak K, Birkan Y, Atalan N, Civelek A, Isbir CS, Arsan S. Effect of AKI on early mortality after cardiac surgery. 2nd Update in Cardiology & Cardiovascular Surgery (20–24 Eyl 2006). Heart Surgery Forum 9(1):S9, 2006. Link: link yok
- Abstract: The relationship between AKI and early mortality.
22) Ak K, Adademir T, Gürsu O, Tekeli A, Atalan N, Tetik S, Isbir S, Arsan S. TEG-based transfusion algorithm reduces blood product use after cardiac surgery. 4th Update in Cardiology & Cardiovascular Surgery (28 Kas–2 Ara 2008). Heart Surgery Forum 11(2):S2, 2008. Link: The Heart Surgery Forum (2008 Suppl)
- Abstract: A thromboelastography (TEG) algorithm reduces transfusions.
23) Ak K, Adademir T, Isbir S, Gürsu O, Tekeli A, Atalan N, Arsan S. Impact of preoperative anemia on outcome after CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S52, 2008. Link: The Heart Surgery Forum (2008 Suppl)
- Abstract: Preoperative anemia is associated with adverse outcomes.
24) Ak K, Isbir S, Tekeli A, Adademir T, Gürsu O, Güler A, Arsan S. Preoperative IABP support in high-risk CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S60, 2008. Link: The Heart Surgery Forum (2008 Suppl)
- Abstract: Experience with intra-aortic balloon pump support in high-risk CABG.
25) Ak K, Tetik Ş, Adademir T, Gürsu Ö, Güler A, Isbir S, Yardımcı T, Arsan S. Impact of early statin therapy on tPA and TFPI after CABG. 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S21, 2009. Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde)
- Abstract: Changes in tPA and TFPI with early statin therapy.
26) Arsan S, Ak K, Adademir T, Güler A, Isbir S. Autologous right PA wall for repair of absent PA (TOF+APV). 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S91, 2009. Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde)
- Abstract: Repair using an autologous pulmonary artery wall graft: a case report.
27) Ergen A, Kahraman TÖ, Tekeli A, Turan AN, Ekşi YE, Adıgüzel M, Isbir S, Isbir T. Plasma myeloperoxidase in MI. 4th International Congress of Molecular Medicine (İstanbul, 27–30 Haz 2011). Link: link yok
- Abstract: The relationship between myeloperoxidase (MPO) levels and myocardial infarction.
28) Kurnaz Ö, Yılmaz AH, Isbir S, Isbir T. PPAR-γ PRO12ALA ve LOX-1 K167N varyantları ve KAH. 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
- Abstract: The association between genetic variants and CAD.
29) Görmüş U, Kahraman TÖ, Isbir S, Tekeli A, Isbir T. MMP2 gen polimorfizmi ve mRNA düzeyi (yüzeyel varis). 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
- Abstract: The relationship between MMP2 and varicose veins.
30) Teker Akadam AB, Yılmaz HA, Arat A, Isbir S, Isbir T. Combined effects of ApoE and PCSK9 R496W in CHD. 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
- Abstract: Combinations of ApoE and PCSK9 variants in relation to CAD.
31) Timirci-Kahraman O, Görmüş U, Ergen HA, Tekeli A, Isbir S, Isbir T. mRNA levels of elastin, fibulin-5, LOXL-1, MMP-2/9 in varicose vein. 22nd IUBMB & 37th FEBS (Sevilla, 4–9 Eyl 2012). Link: link yok
- Abstract: Expression of extracellular matrix-related genes in varicose veins.
32) Birkan Y, Isbir S, Ak K, Elçi E, Dericioğlu O, Arsan S. CD34(+) pluripotent MSC therapy in chronic critical limb ischemia. 14th Asian Society for Vascular Surgery (İstanbul, 26–29 Eki 2013). Link: link yok
- Abstract: CD34(+) mesenchymal stem cell treatment for critical limb ischemia.
33) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S. Five-year results of EVAR for AAA (single center). 14th ASVS (İstanbul, 26–29 Eki 2013). Link: link yok
- Abstract: Five years of single-center experience with EVAR.
34) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S. Endovascular graft repair of thoracic aortic pathologies (single center). 14th ASVS (İstanbul, 26–29 Eki 2013). Link: link yok
- Abstract: Experience with endovascular grafts in the thoracic aorta.
35) Öztürk NY, Ak K, Erkek N, Isbir S, Arsan S. VV-ECMO in pediatric ICU: early experience. 1st International Critical Care & Emergency Medicine Congress (İstanbul, 6–8 Kas 2013). Link: link yok
- Abstract: Experience with venovenous ECMO in pediatric intensive care.
36) Yalındağ NO, Ak K, Besci T, Keleş B, Kolbaş N, Erkek N, Isbir S, Arsan S. VV-ECLS for infant with ARDS & airleaks (first success). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):293, 2013. Link: link yok
- Abstract: Successful venovenous extracorporeal life support (VV-ECLS) in an infant with ARDS.
37) Öztürk NO, Ak K, Yasa U, Barys S, Isbir S, Arsan S, Erkek N, Barlan İ. VV-ECLS weaning without anticoagulation (IPEX, child). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):294, 2013. Link: link yok
- Abstract: Weaning from VV-ECLS without anticoagulation: a case report.
38) Isbir S, Baltacioglu F, Ak K, Kararmaz A, Elçi E, Arsan S. Hybrid procedures for extensive aortic pathologies (22 hasta). AATS Aortic Symposium (New York, 24–25 Nis 2014). Link: link yok
- Abstract: A hybrid approach to extensive aortic disease.
39) Birkan Y, Ak K, Dericioğlu O, Isbir S, Arsan S. CD34(+) MSC therapy in chronic critical limb ischemia. 11th International Congress of Update in Cardiology & Cardiovascular Surgery (26–29 Mar 2015). JACC Suppl S6, 2015. Link: link yok
- Abstract: Stem cell treatment for critical limb ischemia: a congress abstract.
40) Isbir S. Hybrid debranching and endovascular repair of extensive TAAA. EuroPCR (Paris, 19–21 May 2015). Link: EuroPCR 2015 Abstract Book (PDF)
- Abstract: Hybrid debranching and endovascular treatment of thoracoabdominal aortic aneurysms (TAAA).
41) Isbir S, Birkan Y. EVH + MECC + Autotransfusion. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
- Abstract: Experience with endoscopic vein harvesting, MECC and autotransfusion in minimally invasive surgery.
42) Isbir S. Hybrid thoracoabdominal aortic aneurysm repair. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
- Abstract: Experience with hybrid TAAA repair.
43) Isbir S. Sutureless valve replacement as a concomitant procedure. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
- Abstract: Simultaneous sutureless valve replacement.
